IART
Integra LifeSciences Holdings Corporation
IART's fundamentals are strong, but it looks expensive: trading at 90x earnings, more than twice its usual 34x. Analysts expect earnings to hold roughly steady, though they disagree widely on how much.
IART Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Under pressure |
IART's profitability and cash flow are currently healthy, and its revenue is stable, but its balance sheet is under pressure.
IART PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 6.2x | $14.35 | — |
| Cheap | 26x | $4.14 | -71% |
| Fair | 34x | $5.42 | -62% |
| Expensive | 84x | $13.36 | -6.9% |
| Current | 90x | $14.35 | — |
Historical ranges are pointers, not guarantees.
IART's PE is in its expensive range at 90x. On analysts' estimates for next year's earnings, today's price would be 6.2x, in its cheap range.
IART Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Stable | |
| Stable | |
| Stable | |
| Limited | |
| Low |
Analysts expect IART's earnings, revenue and profitability to hold roughly steady. However, they disagree widely on these estimates.
IART Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.33 | +1357% |
| Q3 2026 | $0.16 | +$6.62 |
| Q2 2026 | -$0.10 | +$6.43 |
| Q1 2026 | -$6.47 | -$6.09 |
| Q4 2025 | -$6.74 | -$6.65 |
| Q3 2025 | -$6.46 | -$6.38 |
| Q2 2025 | -$6.53 | -2277% |
| Q1 2025 | -$0.38 | -175% |
| Q4 2024 | -$0.09 | -111% |
IART has returned to profit: it earned $0.16 per share over the past year, after losing money the year before.
IART Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $411.2M | +2.3% |
| Q2 2026 | $418.8M | +0.8% |
| Q1 2026 | $391.9M | +2.4% |
| Q4 2025 | $434.9M | -1.7% |
| Q3 2025 | $402.1M | +5.6% |
| Q2 2025 | $415.6M | -0.6% |
| Q1 2025 | $382.7M | +3.7% |
| Q4 2024 | $442.6M | +11% |
IART's revenue grew through 2021 and has held roughly level since: $411M last quarter, up 2.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 4.6% | +1.7 points |
| Q2 2026 | 4.6% | +128 points |
| Q1 2026 | 2.9% | +7 points |
| Q4 2025 | 5.3% | -2.8 points |
| Q3 2025 | 2.9% | +5.1 points |
| Q2 2025 | -123% | -123 points |
| Q1 2025 | -4% | -5.1 points |
| Q4 2024 | 8.1% | -1 points |
IART's operating margin was 4.6% last quarter, up 1.7 points from the same quarter a year ago.
IART Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $85.7M | +233% |
| Q2 2026 | $10.5M | +$21.7M |
| Q1 2026 | -$5M | +$35.1M |
| Q4 2025 | -$5.4M | -126% |
| Q3 2025 | $25.8M | +$32.9M |
| Q2 2025 | -$11.2M | -205% |
| Q1 2025 | -$40.2M | -13907% |
| Q4 2024 | $21.1M | -38% |
IART's free cash flow has turned positive again: $86M over the past year, against −$5M the year before.
IART Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +409K shares |
| 1 year | +2.4% | +1.8M shares |
| 3 years | -1.5% | -1.2M shares |
| 5 years | -8% | -6.9M shares |
| Available history | -9.2% | -7.9M shares |
IART has 79M diluted shares, up 2.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q4 2024 | $2.5M |
| Q3 2024 | — |
| Q2 2024 | $50M |
| Q1 2024 | — |
| Q4 2023 | — |
IART Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2020 | 3.0x | Elevated |
| Q1 2020 | 2.6x | Moderate |
| Q4 2019 | 3.3x | Elevated |
IART's net debt is about 3.0 years of its operating earnings (EBITDA).
IART Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.5 | Neutral |
| Stochastic | 26.2 | Neutral |
IART's weekly RSI is 49 (neutral) and its Stochastic is 26 (neutral).
IART PE vs Healthcare Sector
| Metric | IART | Sector median | Relative |
|---|---|---|---|
| PE | 90x | 26x | 247% above |
| PE % | 89 | 29 | 60 pts above |
IART is trading at 90x earnings, a 247% premium to the Healthcare sector's median of 26x.
IART Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.5 | 6.5% above |
| 20 week MA | $15.9 | 9.5% below |
| 50 week MA | $13.9 | 3.2% above |
| 100 week MA | $15.3 | 6.1% below |
| 200 week MA | $26.4 | 46% below |
IART's trend is mixed: it's above two of its five weekly moving averages, and 46% below its 200-week average.
IART Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $58.7 | $66.4 | +13% |
| 2021 | $66.4 | $68.3 | +2.8% |
| 2022 | $68.3 | $56.3 | -18% |
| 2023 | $56.3 | $43.6 | -23% |
| 2024 | $43.6 | $22.3 | -49% |
| 2025 | $22.3 | $12.6 | -43% |
| 2026 YTD | $12.6 | $14.4 | +14% |
IART has finished four years in a row lower, and it's up 14% so far in 2026.